| CXSL2400488 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2024-07-27 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2400183 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-07-18 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| JYSB2400153 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-07-16 | | | | | view |
| CYSB2400153 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-06-14 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CYSB2400103 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-05-01 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CYSB2400104 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-05-01 | | Shandong BoAn Biotechnology Co Ltd | | | view |
| CXSL2400202 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2024-03-23 | | Bio-Thera Solutions Ltd | | | view |
| CXSL2400201 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2024-03-23 | | Bio-Thera Solutions Ltd | | | view |
| JYSB2400036 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-02-28 | | | | | view |
| CXSS2400010 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2024-01-17 | | SinoCelltech Ltd | | | view |
| CYSB2300206 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-11-04 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2300202 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-10-31 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2300201 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-10-31 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2300174 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-09-26 | | TOT Biopharm Co Ltd | | | view |
| CYSB2300146 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-07-27 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSS2300058 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-07-26 | | Shanghai Institute of Biological Products Co Ltd | | | view |
| CXSS2300048 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-07-03 | | Hualan Genetic Engineering Co Ltd | | | view |
| JXSL2300111 | 眼用贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-06-20 | | | | | view |
| CYSB2300112 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-06-12 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CXSL2300357 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2023-05-19 | | Bio-Thera Solutions Ltd | | | view |
